Patient-Oriented Evidence That Matters
A Single Corticosteroid Burst in Children Is Associated With Harms
Am Fam Physician. 2022 Jan ;105(1):94-95.
Are steroid bursts in children potentially harmful?
Although corticosteroid bursts have potential for improving outcomes for many acute illnesses, this study shows that the potential harms are not trivial. (Level of Evidence = 3b)
Clinicians widely prescribe corticosteroid bursts to children for multiple indications, assuming that these short courses are harmless. The authors used the national database in Taiwan to conduct a self-controlled case series to evaluate the potential harms associated with a single burst of corticosteroids in children. The database covers 99% of the Taiwanese population and includes insurance claims and prescription data. From this database of more than 4.5 million children, the authors identified 1,897,858 children younger than 18 years who had one or more corticosteroid bursts of 14 days or less. Approximately 42% of all children in the database had at least one exposure to corticosteroid bursts. The gender distribution was roughly equal, and 91% had no comorbid conditions. The most common reasons for the bursts, accounting for 65% of the indications, included acute respiratory infections and allergic conditions. The authors subdivided children into those who received a single burst and those who had more than one burst. The baseline differences between the groups were comparable. The authors comprised data from 90 days before the start and 90 days after the completion of each burst to assemble each case study. As summarized in the table, gastrointestinal bleeding, sepsis, pneumonia, and glaucoma occurred more frequently in children treated with corticosteroid bursts than in untreated children. With the exception of glaucoma, the adverse events occurred more frequently during the first 30 days after treatment and were slightly elevated afterward.
|Adverse event||Corticosteroid bursts||No corticosteroid bursts|
|Incidence per 1,000 person-years (95% CI)||Incidence per 1,000 person-years (95% CI)||Rate difference per 1,000 person-years (95% CI)|
2.48 (2.44 to 2.52)
1.88 (1.86 to 1.90)
0.60 (0.55 to 0.64)
0.37 (0.35 to 0.39)
0.34 (0.33 to 0.34)
0.03 (0.02 to 0.05)
25.74 (25.59 to 25.88)
16.39 (16.32 to 16.45)
9.35 (9.19 to 9.51)
0.62 (0.60 to 0.64)
POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, editor-in-chief.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions